ECOR - エレクトロコア （electroCore Inc.） エレクトロコアECORのチャート
ECORの企業情報
| symbol | ECOR |
|---|---|
| 会社名 | ElectroCore Inc （エレクトロコア） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ElectroCore Inc. formerly ElectroCore LLC is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology psychiatry gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache) and the associated chronic co-morbidities of gastric motility psychiatric sleep and pain disorders. エレクトロコアは米国のバイオエレクトロニクス企業。主に神経系疾患やリウマチなどの治療のために、非侵襲的な迷走神経刺激法の開発に従事する。同社は成人の偏頭痛およびエピソ―ドクラスタ―頭痛の急性疼痛の治療のために、処方箋のみの迷走神経刺激法のgammaCore(ガンマコア)を開発する。本社所在地はニュ―ジャ―ジ―州ベ―スキング・リッジ。 |
| 本社所在地 | 150 Allen Road Suite 201 Basking Ridge NJ 07920 USA |
| 代表者氏名 | J.P. Errico J.P.エリコ |
| 代表者役職名 | Chairman of the Board Co-Founder Principal Investor and Chief Science_Strategy Officer |
| 電話番号 | +1 973-290-0097 |
| 設立年月日 | 38596 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | 64人 |
| url | www.electrocore.com |
| nasdaq_url | https://www.nasdaq.com/symbol/ecor |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -38.75351 |
| 終値（lastsale） | 13.28 |
| 時価総額（marketcap） | 391096451.52 |
| 時価総額 | 時価総額（百万ドル） 386.08990 |
| 売上高 | 売上高（百万ドル） 0.99239 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 290.26335 |
| 当期純利益 | 当期純利益（百万ドル） -45.14816 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 electroCore Inc. revenues increased 62% to $474K. Net loss increased 52% to $27.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative increase from $7.9M to $18.8M (expense) Research and development increase of 48% to $6.7M (expense). |
ECORのテクニカル分析
ECORのニュース
Neurostimulation Devices Market 2020 Global Leaders Overview: Autonomic Technologies, Boston Scientific, ElectroCore, ImThera Medical, Inspire Medical Systems, LivaNova (Cyberonics) and others 2020/12/14 14:15:53 OpenPR
Market Scenario: Neurostimulation is a modulation of the nervous system’s activity. It is deliberately carried out by using invasive and non-invasive techniques. Implantable stimulation devices are most commonly used in the treatment of the neurological conditions such as epilepsy, Parkinson’s disease,
electroCore to Announce Third Quarter Ended September 30, 2020 Financial Results on Thursday, November 12 2020/11/05 13:00:00 GlobeNewswire
Conference Call to be Held at 4:30pm Eastern Time
Contrasting Micron Solutions (OTCMKTS:MICR) & electroCore (OTCMKTS:ECOR) 2020/10/25 05:56:45 Dispatch Tribunal
Micron Solutions (OTCMKTS:MICR) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Risk and Volatility Micron Solutions has a beta of 0.15, indicating that its share price is […]
Migraine Treatment Market 2020 Analysis by Latest COVID19/CORONA Virus Impact with Market Positioning of Key Vendors: Abbott, Cefaly Technology, Aegis Theraputics, LLC, Electrocore, Inc, Aerial BioPharma LLC 2020/10/21 18:27:37 OpenPR
Data Bridge Market Research has recently added a concise research on the Global Migraine Treatment Market - Industry Trends and Forecast to 2026. Global Migraine Treatment Market research report has been prepared with a nice combination of industry insight, smart
Bioelectric Medicine Market SWOT Analysis by Key Players: Boston Scientific, Cochlear, electroCore 2020/10/06 09:42:35 OpenPR
A new independent 169 page research with title 'Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity' is a perfect blend of quant and qualitative data to make better informed
Neurostimulation Devices Market 2020 Global Leaders Overview: Autonomic Technologies, Boston Scientific, ElectroCore, ImThera Medical, Inspire Medical Systems, LivaNova (Cyberonics) and others 2020/12/14 14:15:53 OpenPR
Market Scenario: Neurostimulation is a modulation of the nervous system’s activity. It is deliberately carried out by using invasive and non-invasive techniques. Implantable stimulation devices are most commonly used in the treatment of the neurological conditions such as epilepsy, Parkinson’s disease,
electroCore to Announce Third Quarter Ended September 30, 2020 Financial Results on Thursday, November 12 2020/11/05 13:00:00 GlobeNewswire
Conference Call to be Held at 4:30pm Eastern Time
Contrasting Micron Solutions (OTCMKTS:MICR) & electroCore (OTCMKTS:ECOR) 2020/10/25 05:56:45 Dispatch Tribunal
Micron Solutions (OTCMKTS:MICR) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Risk and Volatility Micron Solutions has a beta of 0.15, indicating that its share price is […]
Migraine Treatment Market 2020 Analysis by Latest COVID19/CORONA Virus Impact with Market Positioning of Key Vendors: Abbott, Cefaly Technology, Aegis Theraputics, LLC, Electrocore, Inc, Aerial BioPharma LLC 2020/10/21 18:27:37 OpenPR
Data Bridge Market Research has recently added a concise research on the Global Migraine Treatment Market - Industry Trends and Forecast to 2026. Global Migraine Treatment Market research report has been prepared with a nice combination of industry insight, smart
Bioelectric Medicine Market SWOT Analysis by Key Players: Boston Scientific, Cochlear, electroCore 2020/10/06 09:42:35 OpenPR
A new independent 169 page research with title 'Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity' is a perfect blend of quant and qualitative data to make better informed
Contrasting Micron Solutions (OTCMKTS:MICR) & electroCore (OTCMKTS:ECOR) 2020/10/25 05:56:45 Dispatch Tribunal
Micron Solutions (OTCMKTS:MICR) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Risk and Volatility Micron Solutions has a beta of 0.15, indicating that its share price is […]
Migraine Treatment Market 2020 Analysis by Latest COVID19/CORONA Virus Impact with Market Positioning of Key Vendors: Abbott, Cefaly Technology, Aegis Theraputics, LLC, Electrocore, Inc, Aerial BioPharma LLC 2020/10/21 18:27:37 OpenPR
Data Bridge Market Research has recently added a concise research on the Global Migraine Treatment Market - Industry Trends and Forecast to 2026. Global Migraine Treatment Market research report has been prepared with a nice combination of industry insight, smart
Bioelectric Medicine Market SWOT Analysis by Key Players: Boston Scientific, Cochlear, electroCore 2020/10/06 09:42:35 OpenPR
A new independent 169 page research with title 'Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity' is a perfect blend of quant and qualitative data to make better informed